| dc.creator |
YAVUZ, And |
|
| dc.creator |
SEZİK, Mekin |
|
| dc.creator |
Ozmen, Ozlem |
|
| dc.creator |
AŞCI, Halil |
|
| dc.date |
2017-10-31T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T09:27:13Z |
|
| dc.date.available |
2020-10-06T09:27:13Z |
|
| dc.identifier |
173db97c-602d-4719-87c1-768f4ee64fd0 |
|
| dc.identifier |
10.1111/jog.13444 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/173db97c-602d-4719-87c1-768f4ee64fd0/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/54188 |
|
| dc.description |
AimFingolimod is a sphingosine-1-phosphate receptor modulator used for multiple sclerosis treatment and acts on cellular processes such as apoptosis, endothelial permeability, and inflammation. We hypothesized that fingolimod has a positive effect on alleviating preterm fetal brain injury. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Fingolimod against endotoxin-induced fetal brain injury in a rat model |
|
| dc.type |
info:eu-repo/semantics/article |
|